Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 6/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 6/20 | 0.33 |
| ▸ | WNT1 | P04628 | 5/20 | 0.33 |
| ▸ | ADH5 | P11766 | 3/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | TTK | P33981 | 2/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4416789 | 0.90 | ACACB (0.38) | GSK3BDYRK1AWNT1ADH5SSTR5 | |
| SCHEMBL4427891 | 0.88 | SSTR5 (0.37) | ADH5SSTR5CSF1RMAP4K4IRAK4 | |
| SCHEMBL4424719 | 0.88 | CYP2D6 (0.32) | GSK3BDYRK1AWNT1SSTR5IRAK4 | |
| SCHEMBL4412902 | 0.88 | ACACB (0.41) | GSK3BDYRK1AWNT1ADH5SSTR5 | |
| SCHEMBL2599528 | 0.87 | SSTR5 (0.39) | GSK3BDYRK1AWNT1SSTR5 | |
| SCHEMBL4412864 | 0.87 | SSTR5 (0.34) | GSK3BDYRK1AWNT1ADH5SSTR5 | |
| SCHEMBL4423563 | 0.86 | TTK (0.33) | GSK3BDYRK1AWNT1ADH5TTK | |
| SCHEMBL4427980 | 0.86 | GSK3B (0.33) | GSK3BDYRK1AWNT1SSTR5CSF1R | |
| SCHEMBL4418731 | 0.85 | GSK3B (0.32) | GSK3BDYRK1AWNT1SSTR5IRAK4 | |
| SCHEMBL4423082 | 0.84 | IRAK4 (0.33) | GSK3BDYRK1AWNT1CSF1RTTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120569-A2 | SPIROCHROMANON DERIVATIVES | Merck & Co., Inc. (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008088692-A2 | SPIROCHROMANON DERIVATIVES | MERCK & CO., INC. (US) | 2008-07-24 | — | — | WO | claimed |
| EP-2120569-A2 | SPIROCHROMANON DERIVATIVES | Merck & Co., Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008088692-A2 | SPIROCHROMANON DERIVATIVES | MERCK & CO., INC. (US) | 2008-07-24 | — | — | WO | disclosed |